Illumina Debuts BioInsight Platform, Expands AI Tools for Genomic Research

09:54 AM EDT, 10/14/2026 (MT Newswires) -- Illumina (ILMN) launched its BioInsight Platform, combining genomic analysis tools, AI models and biological datasets to simplify genomic and multiomic research, the company said Wednesday. The platform includes DRAGEN v4.6, which expands deployment options across supported cloud and CPU environments while maintaining consistent analysis results, the company said. The platform integrates applications such as Emedgene, Connected Multiomics and BaseSpace, curated biological datasets, and usage-based BioInsight Credits that replace annual subscriptions, the company added. Illumina shares were up 2% in Wednesday trading. Price: 275.04, Change: +3.87, Percent Change: +1.43